tiprankstipranks
Advertisement
Advertisement

Candel Therapeutics 18.3M share Spot Secondary priced at $5.45

The deal range was $5.45-$5.65. LifeSci Capital acted as lead book running manager for the offering.

Claim 55% Off TipRanks

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1